Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- EMD.AU
- Price
- 0.06
- Stock movement up
- +0.00 (1.75%)
- Company name
- Emyria Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Health Information Services
- Market cap
- 46.78M
- Ent value
- 37.83M
- Price/Sales
- 11.85
- Price/Book
- 3.87
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -25.60%
- 1 year return (CAGR)
- 65.71%
- 3 year return (CAGR)
- -35.88%
- 5 year return (CAGR)
- -23.05%
- 10 year return (CAGR)
- -
Last updated: 2026-03-13
DIVIDENDS
EMD.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 11.85 |
| Price to Book | 3.87 |
| EV to Sales | 9.59 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 806.56M |
| EPS (TTM) | -0.01 |
| FCF per share (TTM) | -0.01 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 3.95M |
| Gross profit (TTM) | -1.41M |
| Operating income (TTM) | -6.80M |
| Net income (TTM) | -6.18M |
| EPS (TTM) | -0.01 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -35.62% |
| Operating margin (TTM) | -172.39% |
| Profit margin (TTM) | -156.57% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 10.50M |
| Net receivables | 249.55K |
| Total current assets | 11.02M |
| Goodwill | 0.00 |
| Intangible assets | 1.84M |
| Property, plant and equipment | 0.00 |
| Total assets | 13.66M |
| Accounts payable | 840.49K |
| Short/Current long term debt | 1.06M |
| Total current liabilities | 1.02M |
| Total liabilities | 1.56M |
| Shareholder's equity | 12.10M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -4.53M |
| Capital expenditures (TTM) | 218.52K |
| Free cash flow (TTM) | -4.75M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -51.07% |
| Return on Assets | -45.25% |
| Return on Invested Capital | -50.83% |
| Cash Return on Invested Capital | -39.05% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.06 |
| Daily high | 0.06 |
| Daily low | 0.06 |
| Daily Volume | 99K |
| All-time high | 0.49 |
| 1y analyst estimate | - |
| Beta | 0.05 |
| EPS (TTM) | -0.01 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| EMD.AU | S&P500 | |
| Current price drop from All-time high | -88.28% | -1.82% |
| Highest price drop | -95.35% | -56.47% |
| Date of highest drop | 12 Jun 2025 | 9 Mar 2009 |
| Avg drop from high | -62.17% | -10.84% |
| Avg time to new high | 69 days | 12 days |
| Max time to new high | 1067 days | 1805 days |
COMPANY DETAILS
Marketcap
46.78M
Marketcap category
Small-cap
Description
Emyria Limited engages in delivering and developing of treatments for mental health and select neurological conditions in Australia. The company operates through Clinical Services, Clinical Services, and corporate segments. It provides therapy programs for post-traumatic stress disorder (PTSD) and treatment-resistant depression. The company also develops ultra-pure CBD capsules (EMD-RX7, and EMD-RX9) and proprietary MDMA analogues, as well as provides psychological trauma care facility under the Pax Centre name. It has a collaboration partnership with the University of Western Australia to support the expand Emyria's MDMA analogue drug development program. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was incorporated in 2018 and is headquartered in Leederville, Australia.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found